Seasonal influenza virus vaccine trivalent - Fluart Innovative Vaccines
Alternative Names: FAB 3511; FAB 6011; FAB 9011; FLUVAL AB; FLUVAL K; Intransal seasonal influenza virus vaccine - Fluart Innovative Vaccines; Low-dose seasonal influenza virus vaccine trivalent - Fluart Innovative Vaccines; Nazoflu; Trivalent seasonal influenza virus vaccine - Fluart Innovative VaccinesLatest Information Update: 07 Oct 2021
At a glance
- Originator Omninvest
- Developer Fluart Innovative Vaccines; Omninvest
- Class Influenza virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Influenza virus infections
Most Recent Events
- 07 Oct 2021 Discontinued - Phase-III for Influenza virus infections (In adolescents, In children, Prevention) in Hungary (IM)
- 17 Jan 2017 No development reported - Phase-III for Influenza virus infections (In adolescents, In children, Prevention) in Hungary (IM)
- 15 Oct 2014 Phase-III clinical trials in Influenza virus infections (Prevention, In children, In adolescents) in Hungary (IM)